Browse > Article
http://dx.doi.org/10.15204/jkobgy.2018.31.4.039

Electroacupuncture for Treatment of Polycystic Ovarian Syndrome: Systematic Review of Randomized Controlled Trials  

Yoon, Jun-Geol (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Park, Nam-Chun (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Ji, Hae-Ri (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Park, Kyoung-Sun (Dept. of Korean Medicine Gynecology, College of Korean Medicine, Kyung Hee University)
Hwang, Deok-Sang (Dept. of Korean Medicine Gynecology, College of Korean Medicine, Kyung Hee University)
Lee, Jin-Moo (Dept. of Korean Medicine Gynecology, College of Korean Medicine, Kyung Hee University)
Lee, Chang-Hoon (Dept. of Korean Medicine Gynecology, College of Korean Medicine, Kyung Hee University)
Jang, Jun-Bock (Dept. of Korean Medicine Gynecology, College of Korean Medicine, Kyung Hee University)
Publication Information
The Journal of Korean Obstetrics and Gynecology / v.31, no.4, 2018 , pp. 39-53 More about this Journal
Abstract
Objectives: The purpose of this review was to overview and evaluate the efficacy of electroacupunture for women with polycystic ovarian syndrome (PCOS) Methods: Relevant randomized controlled studies (RCTs) were identified by database searches in PubMED, EMBASE, OASIS, and Google scholar, up to May 2018. Data were extracted regarding hyperandrogenism, obesity and hyperinsulinemia indices. The risk of bias was assessed. Results: Five RCTs were included for analysis. In one RCT, electroacupuncture group had significantly lower free testosterone and testosterone, compared to no treatment group. However, The other RCTs showed no significant difference between two groups. For LH/FSH, Ferriman Gallway score, anti-mullerian hormone, body mass index, weight and waist, and insulin, electroacupuncture group showed no significant difference, compared to physical exercise, no treatment, and sham acupuncture group. Conclusions: Only a limited number of RCTs have been reported. At present, there is insufficient evidence to support the use of electroacupuncture for treatment of PCOS.
Keywords
Polycystic Ovarian Syndrome; Electroacupuncture; Korean Medicine Therapy; Randomized Controlled Trials;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Min WG. Polycystic Ovary Syndrome. J Korean Obstet Gynecol. 2008;51(8):805-19.
2 Korean Society of Obstetrics and Gynecology. Gynecology. 5th edition. Seoul:Korea Medical Book Publishing Company(KOMB). 2015:488.
3 Koo BS, et al. Clinical Gynecologic Endocrinology. Seoul:Korea Medical Book Publishing Company. 2001:181-3.
4 Byun EG, et al. The Prevalence of Polycystic Ovary Syndrome in College Students from Seoul. Endocrinology and metabolism. 2005;20(1):120-6.
5 Kim DI, Yoon JW, Lee TG. A bibliographical study on Polycystic ovarian syndrome. J Korean Obstet Gynecol. 1997;10(1):73-91.
6 Teede H, Deeks A, Moran L. Polycystic ovary syndrome; a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Medicine. 2010;8:41.   DOI
7 Kim T. Current View of Polycystic ovarian syndrome. Korean Society of Obstetrics and Gynecology. 2002;31:38-44.
8 Lanham MS, et al. A meta-anaylsis of pregnancy outcomes in women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2006;95:236-41.   DOI
9 Jo J, Lee YJ. Effectiveness of acupuncture in women with polycystic ovarian syndrome undergoing in vitro fertilisation or intracytoplasmic sperm injection: a systematic review and meta-analysis. Acupunt Med. 2017;35(3):162-70.   DOI
10 Kim SH, et al. Recent Acupuncture Therapy for polycystic ovary syndrome; systematic review. J Korean Obstet Gynecol. 2014;27(2):71-82.   DOI
11 Lim C, et al. Acupuncture for polycystic ovarian syndrome. Cochrane database of systematic reviews. 2016;5.
12 Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[cited February 4, 2017]. Available from: URL:http://handbook.cochrane.org.
13 Stener-Victorin E, et al. Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome. Am J Physiol Regul Integr Comp Physiol 2009;297(2):R387-95.   DOI
14 Franasiak J, et al. Longitudinal Anti-Mullerian Hormone in women with polycystic ovary syndrome: An acupuncture randomized clinical trial. Evidence-Based Complementary and Alternative Medicine. 2012.
15 Jedel E, et al. Impact of electroacupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol Metab 2011;300(1):E37-45.   DOI
16 Stener-Victorin E, et al. Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndorme: secondary analyses of a randomized controlled trial. Fertility and Sterility. 2012;97(2):501-8.   DOI
17 Pastore LM, et al. True and Sham acupuncture produced similar frequency of ovulation and improved LH to FSH ratios in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96(10):3143-50.   DOI
18 Lee JD. The Acupuncture and Moxibustion (Volume II). Kyungki:Jibmoondang. 2008:364-71.
19 Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health.
20 Yoon SY, Kang MJ. Clinical Study of Oriental Medicine Treatment for Polycystic Ovarian Disease. J Korean Obstet Gynecol. 2000;13(2):437-51.
21 Lee JH. Electrotherapy. 2nd. Seoul: DaihakSeorim. 2002:665-7.
22 Jung YP, et al. The Clinical Study of Electroacupuncture Treatment at Hua-Tuo-Jia-Ji-Xue on Spondylolisthesis. The Journal of Korean Acupuncture and Moxibustion Society. 2008;25(1):221-32.
23 Moon JS, et al. A Survey on the Use of Electroacupuncture by Traditional Korean Medicine Doctor. The Journal of Korean Acupuncture and Moxibustion Society. 2011;28(6):53-68.
24 Dunaif A. Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis. Endocrine Reviews. 1997;18(6):774-800.   DOI
25 Lansdown A, Rees DA. The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target. Clinical Endocrinology 2012;77(6):791-801.   DOI
26 Park SR. Effects of electro-acupuncture on Samumgyo(SP-6).Chagung(CA-111) on polycystic ovary in rats. Graduate school, Dongshin University. 2003.
27 Novak E. Berek & Novak's gynecology. Philadelphia:Lippincott Williams & Wilkins. 2007:1072.
28 Wijeyaratne CN, et al. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference. Clinical endocrinology. 2002;57(3):343-50.   DOI
29 Fallat ME, et al. Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertil. Steril. 1997;67(5):962-5.   DOI
30 Grossman MP, et al. Mullerianinhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil. Steril. 2008;89(5 Suppl):1364-70.   DOI
31 Mulders AG, et al. Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum. Reprod. 2004;19(9):2036-42.   DOI
32 Pellatt L, et al. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J. Clin. Endocrinol. Metab. 2007;92(1):240-5.   DOI
33 Ann YG. Kyunghyulhakchongseo(經穴學叢書). Seoul:Sungbosa. 1986:228-9, 678-9.
34 Wild RA. Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med. 1995;98(1A):27S-32S.   DOI
35 Barbieri RL, Ryan KJ. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol. 1983;147(1):90-101.   DOI
36 Ehrmann DA. Polycytic ovary syndrome. N Engl J Med. 2005;352:1223-36.   DOI
37 Laven JS, et al, Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J. Clin. Endocrinol. Metab. 2004;89(1):318-23.   DOI